Findings

What do systematic reviews say?

3 questions · 3 findings · 2 reviews · Lung Cancer

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 33.3%Moderate 1 · 33.3%High 1 · 33.3%

1‐Year survival rate · combination with third‐generation drugs for advanced non‐small cell lung cancer

Carboplatin showed no clear difference in 1‐year survival rate compared with cisplatin chemotherapy (high certainty).

1 finding from 1 review

1‐Year survival rate · non‐small cell lung cancer in the elderly population

Non‐platinum therapies probably leads to lower 1‐Year survival rate compared with platinum combination (moderate certainty).

1 finding from 1 review

Chemotherapy for advanced non‐small cell lung cancer in the elderly population 2015 · Cochrane Headline outcomes only
RR 0.89
13 studies · 813 participants
Moderate

1‐Year survival rate (OS1y) · non‐small cell lung cancer in the elderly population

Non‐platinum single‐agent may leads to lower 1‐Year survival rate (OS1y) compared with non‐platinum combination treatment (low certainty).

1 finding from 1 review

Chemotherapy for advanced non‐small cell lung cancer in the elderly population 2015 · Cochrane Headline outcomes only
RR 0.88
4 studies · 993 participants
Low